5th Annual AsiaTides – Oligonucleotide & Peptide, 26-28 February 2013, Tokyo, Japan

5th Annual AsiaTides – Oligonucleotide & Peptide

Date:  26-28 February 2013
Venue: Sheraton Miyako Hotel, Tokyo, Japan

Now in its 5th year, AsiaTIDES continues to be the premier forum to get a comprehensive update, meet key players and increase your knowledge of the oligonucleotide- and peptide-based therapeutics fields.

 

Hear the latest reports from RXi, Tekmira, Santaris, miRagen, Arrowhead, REPLICor, Noxxon, Silence, PeptiDream, Ironwood, Pfizer, Immunovaccine, OncoTherapy Science, Zealand, Radius, Aileron and more. Learn manufacturing capabilities of all the major oligonucleotide and peptide CMOs.

 

With the latest updates on science, business developments and regulatory changes, as well as the practical tutorials, this event is your best conference choice to update your knowledge in all the relevant areas in three short days.

 

Only Available at AsiaTIDES

Clinical Milestones to Benchmark Your Progress
Latest Updates to Strategically Plan Your Process and Portfolio Development:

• Discovery and Preclinical Development
• Clinical Development of siRNA, miRNA, Aptamers, and Other Oligo Classes
• Conjugates, Peptide Therapeutics, and Vaccines
• Manufacturing and Analytical Challenges Session

In-Depth Tutorials to Update your Knowledge:

• Quality by Design/In Process Control Requirements
• Successful Delivery of Oligonucleotides in vivo: Chemical Modifications and DDS (Drug Delivery Systems)

For more information,

Call: + 65 6508 2401

Email: register@ibcasia.com.sg

Web: www.ibclifesciences.com/AsiaTIDES